ftInvstr
WANBURY · Healthcare ₹244.25 -0.31% Mkt Cap ₹846 Cr
← Search another stock

WANBURY

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹244.25
-0.31% today · 30d -10.86%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for WANBURY. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2025-06-30
REVENUE
₹163 Cr
+24.47% YoY
NET PROFIT
₹13 Cr
+1200.41% YoY
OPM
15.16%
+6.13pp YoY
EPS
₹4.12
PE 15.37
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
WANBURY15.3737.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
60
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation CHEAP 75
Growth DECLINING 29
Profitability HIGH 88
Technicals WEAK 38
Risk LOW 90
Key Stats
TTM PE
15.37
P/B
5.19
52W HIGH
₹358.85
OFF HIGH
-31.94%
MKT CAP
₹846 Cr
◉ Active Signals
MACDBearish-0.3841
RSI(14)Bearish34.31
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold WANBURY and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.